![]() | Up a level |
Agha, Mounzer E., Cohen, Adam D., Madduri, Deepu, Cohen, Yael C., Delforge, Michel, Hillengass, Jens, Goldschmidt, Hartmut, Weisel, Katja, Raab, Marc-Steffen, Scheid, Christof, Schecter, Jordan Mark, De Braganca, Kevin C., Varsos, Helen, Wang, Liwei, Vogel, Martin, Carrasco-Alfonso, Marlene, Akram, Muhammad, Wu, Xiaoling, Nesheiwat, Tonia and Einsele, Hermann (2021). CARTITUDE-2: Efficacy and safety of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR T-cell therapy, in patients with progressive multiple myeloma (MM) after one to three prior lines of therapy. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755
Baertsch, Marc-A., Schlenzka, Jana, Christina, Habermehl, Hielscher, Thomas, Raab, Marc S., Hillengass, Jens, Mueller-Tidow, Carsten, Luntz, Steffen, Jauch, Anna, Brossart, Peter, Goerner, Martin, Klein, Stefan A., Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Haenel, Mathias, Martin, Hans, Lindemann, Hans-Walter, Scheid, Christoph, Nogai, Axel, Salwender, Hans Juergen, Noppeney, Richard, Weisel, Katja and Goldschmidt, Hartmut (2018). Subgroup Analyses of the Randomized GMMG Phase III Multicenter Trial Relapse Suggest Survival Benefit of Salvage Autologous Transplant Primarily in Low Risk Multiple Myeloma. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Baertsch, Marc-Andrea, Schlenzka, Jana, Lisenko, Katharina, Krzykalla, Julia, Becker, Natalia, Weisel, Katja, Noppeney, Richard, Martin, Hans, Lindemann, Hans W., Haenel, Mathias, Nogai, Axel, Scheid, Christof, Salwender, Hans ORCID: 0000-0001-7803-0814, Fenk, Roland, Graeven, Ullrich, Reimer, Peter, Schmidt-Hieber, Martin, Goerner, Martin, Schmidt-Wolf, Ingo G. H., Klein, Stefan, Ho, Anthony D., Goldschmidt, Hartmut and Wuchter, Patrick
(2017).
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE.
Eur. J. Haematol., 99 (1).
S. 42 - 51.
HOBOKEN:
WILEY.
ISSN 1600-0609
Baertsch, Marc-Andrea, Schlenzka, Jana, Mai, Elias K., Merz, Maximilian, Hillengass, Jens, Raab, Marc S., Hose, Dirk, Wuchter, Patrick, Ho, Anthony D. ORCID: 0000-0002-1656-0833, Jauch, Anna, Hielscher, Thomas, Kunz, Christina, Luntz, Steffen, Klein, Stefan, Schmidt-Wolf, Ingo G. H., Goerner, Martin, Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Salwender, Hans
ORCID: 0000-0001-7803-0814, Scheid, Christof, Nogai, Axel, Haenel, Mathias, Lindemann, Hans W., Martin, Hans, Noppeney, Richard, Weisel, Katja and Goldschmidt, Hartmut
(2016).
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma.
BMC Cancer, 16.
LONDON:
BMC.
ISSN 1471-2407
Goldschmidt, Hartmut, Baertsch, Marc-A., Schlenzka, Jana, Becker, Natalia, Christina, Habermehl, Hielscher, Thomas, Raab, Marc S., Hillengass, Jens, Mueller-Tidow, Carsten, Luntz, Steffen, Jauch, Anna, Brossart, Peter, Goerner, Martin, Klein, Stefan A., Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Haenel, Mathias, Martin, Hans, Lindemann, Hans-Walter, Scheid, Christoph, Nogai, Axel, Salwender, Hans Juergen, Noppeney, Richard and Weisel, Katja (2018). Salvage Autologous Transplant and Lenalidomide Maintenance Versus Continuous Lenalidomide/Dexamethasone for Relapsed Multiple Myeloma: Results of the Randomized GMMG Phase III Multicenter Trial Relapse. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Goldschmidt, Hartmut, Baertsch, Marc-Andrea, Schlenzka, Jana, Becker, Natalia, Habermehl, Christina, Hielscher, Thomas, Raab, Marc-Steffen, Hillengass, Jens, Sauer, Sandra, Mueller-Tidow, Carsten, Luntz, Steffen, Jauch, Anna, Hose, Dirk, Seckinger, Anja, Brossart, Peter, Goerner, Martin, Klein, Stefan, Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Haenel, Mathias, Martin, Hans, Lindemann, Hans W., Scheid, Christoph, Nogai, Axel, Salwender, Hans, Noppeney, Richard, Besemer, Britta and Weisel, Katja . Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE. Leukemia. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Hose, Dirk, Beck, Susanne, Salwender, Hans, Emde, Martina, Bertsch, Uta, Kunz, Christina, Scheid, Christoph, Haenel, Mathias, Weisel, Katja, Hielscher, Thomas, Raab, Marc S., Goldschmidt, Hartmut, Jauch, Anna, Moreaux, Jerome ORCID: 0000-0002-5717-3207 and Seckinger, Anja
(2019).
Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial.
J. Hematol. Oncol., 12.
LONDON:
BMC.
ISSN 1756-8722
Jansen, Lina, Merz, Maximilian, Engelhardt, Monika, Weisel, Katja, Scheid, Christof, Straka, Christian, Langer, Christian, Salwender, Hans, Einsele, Hermann, Kroege, Nikolaus, Beelen, Dietrich W., Dreger, Peter, Goldschmidt, Hartmut and Brenner, Hermann ORCID: 0000-0002-6129-1572
(2020).
Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects.
Leuk. Lymphoma, 61 (10).
S. 2365 - 2375.
ABINGDON:
TAYLOR & FRANCIS LTD.
ISSN 1029-2403
Mai, Elias K., Huhn, Stefanie, Miah, Kaya, Poos, Alexandra M., Scheid, Christof, Weisel, Katja, Bertsch, Uta, Munder, Markus, Berlanga, Oscar, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Blau, Igor Wolfgang, Haenel, Mathias, Salwender, Hans, Benner, Axel, Raab, Marc S., Goldschmidt, Hartmut and Weinhold, Niels (2022). Implications and Prognostic Impact of Mass Spectrometry in Patients with Newly-Diagnosed Multiple Myeloma. Blood, 140. S. 2341 - 2344. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Mateos, Maria-Victoria, Weisel, Katja ORCID: 0000-0001-9422-6614, De Stefano, Valerio
ORCID: 0000-0002-5178-5827, Goldschmidt, Hartmut, Delforge, Michel, Mohty, Mohamad
ORCID: 0000-0002-7264-808X, Cavo, Michele, Vij, Ravi, Lindsey-Hill, Joanne, Dytfeld, Dominik, Angelucci, Emanuele, Perrot, Aurore
ORCID: 0000-0003-0131-8689, Benjamin, Reuben
ORCID: 0000-0003-1434-0594, van de Donk, Niels W. C. J., Ocio, Enrique M., Scheid, Christof, Gay, Francesca, Roeloffzen, Wilfried, Rodriguez-Otero, Paula, Broijl, Annemiek, Potamianou, Anna, Sakabedoyan, Caline, Semerjian, Maria, Keim, Sofia, Strulev, Vadim, Schecter, Jordan M., Vogel, Martin, Wapenaar, Robert, Nesheiwat, Tonia, San-Miguel, Jesus, Sonneveld, Pieter, Einsele, Hermann and Moreau, Philippe
(2022).
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma.
Leukemia, 36 (5).
S. 1371 - 1377.
LONDON:
SPRINGERNATURE.
ISSN 1476-5551
Merz, Maximilian, Jansen, Lina ORCID: 0000-0001-8004-4940, Castro, Felipe A., Hillengass, Jens, Salwender, Hans
ORCID: 0000-0001-7803-0814, Weisel, Katja, Scheid, Christof, Luttmann, Sabine, Emrich, Katharina, Holleczek, Bernd, Katalinic, Alexander
ORCID: 0000-0003-0490-1554, Nennecke, Alice, Straka, Christian, Langer, Christian, Engelhardt, Monika, Einsele, Hermann, Kroeger, Nicolaus, Beelen, Dietrich, Dreger, Peter, Brenner, Hermann
ORCID: 0000-0002-6129-1572 and Goldschmidt, Hartmut
(2016).
Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation.
Eur. J. Cancer, 62.
S. 1 - 9.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
Merz, Maximilian, Jauch, Anna, Hielscher, Thomas, Mai, Elias K., Seckinger, Anja, Hose, Dirk, Bertsch, Uta, Neben, Kai, Raab, Marc S., Salwender, Hans ORCID: 0000-0001-7803-0814, Blau, Igor W., Lindemann, Hans-Walter, Schmidt-Wolf, Ingo, Scheid, Christof, Haenel, Mathias, Weisel, Katja, Goldschmidt, Hartmut and Hillengass, Jens
(2017).
Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation.
Haematologica, 102 (8).
S. 1432 - 1439.
PAVIA:
FERRATA STORTI FOUNDATION.
ISSN 0390-6078
Merz, Maximilian, Salwender, Hans, Haenel, Mathias, Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W., Scheid, Christof, Mai, Elias Karl ORCID: 0000-0002-6226-1252, Hose, Dirk, Schurich, Baerbel, Munder, Markus, Schmidt-Wolf, Ingo G. H., Gerecke, Christian, Lindemann, Hans Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan and Goldschmidt, Hartmut
(2014).
Subcutaneous Versus Intravenous Bortezomib in Two Different Induction Therapies for Newly Diagnosed Multiple Myeloma - Subgroup Analysis from the GMMG-MM5 Trial.
Blood, 124 (21).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020
Merz, Maximilian, Salwender, Hans ORCID: 0000-0001-7803-0814, Haenel, Mathias, Mai, Elias K., Bertsch, Uta, Kunz, Christina, Hielscher, Thomas, Blau, Igor W., Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Hillengass, Jens, Raab, Marc S., Schurich, Baerbel, Munder, Markus, Brossart, Peter, Gerecke, Christian, Lindemann, Hans-Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan and Goldschmidt, Hartmut
(2016).
Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.
Haematologica, 101 (12).
S. E485 - 3.
PAVIA:
FERRATA STORTI FOUNDATION.
ISSN 0390-6078
Salwender, Hans, Bertsch, Uta, Weisel, Katja, Duerig, Jan, Kunz, Christina, Benner, Axel, Blau, Igor W., Raab, Marc Steffen, Hillengass, Jens, Hose, Dirk, Huhn, Stefanie, Hundemer, Michael, Andrulis, Mindaugas, Jauch, Anna, Seidel-Glaetzer, Andrea, Lindemann, Hans-Walter, Hensel, Manfred, Fronhoffs, Stefan, Martens, Uwe, Hansen, Timon, Wattad, Mohammed, Graeven, Ullrich, Munder, Markus, Fenk, Roland, Haenel, Mathias, Scheid, Christof and Goldschmidt, Hartmut (2019). Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma. BMC Cancer, 19. LONDON: BMC. ISSN 1471-2407
Salwender, Hans, Elmaagacli, Ahmet, Merz, Maximilian, Miah, Kaya, Benner, Axel, Haenel, Mathias, Jehn, Christian, Mai, Elias K., Bertsch, Uta, Blau, Igor W., Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Raab, Marc S., Luntz, Steffen P., Besemer, Britta, Munder, Markus, Brossart, Peter, Fuhrmann, Stephan, Lindemann, Hans-Walter, Weisel, Katja, Duerig, Jan and Goldschmidt, Hartmut (2021). Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial. Leukemia, 35 (10). S. 3007 - 3012. LONDON: SPRINGERNATURE. ISSN 1476-5551
Scheid, Christof, Hielscher, Thomas, Bertsch, Uta, Kunz, Christina, Salwender, Hans, Haenel, Mathias, Merz, Maximilian, Mai, Elias Karl ORCID: 0000-0002-6226-1252, Hose, Dirk, Schurich, Baerbel, Munder, Markus, Schmidt-Wolf, Ingo, Gerecke, Christian, Lindemann, Walter, Zeis, Matthias, Weisel, Katja, Duerig, Jan, Jauch, Anna and Goldschmidt, Hartmut
(2014).
Influence of Renal Impairment and Genetic Risk Factors on Response to Induction Therapy in the HD4 and MM5 Trials of the GMMG.
Blood, 124 (21).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020
Seckinger, Anja, Salwender, Hans Juergen, Martin, Hans, Scheid, Christof, Hielscher, Thomas, Bertsch, Uta, Hummel, Manuela, Jauch, Anna, Knauf, Wolfgang, Emde, Martina, Beck, Susanne, Neben, Kai, Lokhorst, Henk M., van der Holt, Bronno, Duehrsen, Ulrich, Duerig, Jan, Lindemann, Hans-Walter, Schmidt-Wolf, Ingo, Haenel, Mathias, Lathan, Bernd, Raab, Marc S., Mueller-Tidow, Carsten, Sonneveld, Pieter, Blau, Igor Wolfgang, Hillengass, Jens, Weisel, Katja, Goldschmidt, Hartmut and Hose, Dirk (2018). Treatment Response and Long-Term Survival in Multiple Myeloma in the GMMG-HD4 Trail - Neither Profit All Molecular Entities Alike, Nor Are Remissions to Different Regimen Equal. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Stroh, Jacob, Seckinger, Anja, Heider, Michael, Rudelius, Martina, Eichner, Ruth ORCID: 0000-0002-8433-9452, Schick, Markus, Slawska, Jolanta, Emde-Rajaratnam, Martina, Salwender, Hans, Bertsch, Uta, Goldschmidt, Hartmut, Weisel, Katja, Scheid, Christof, Keller, Ulrich, Hose, Dirk and Bassermann, Florian
(2022).
MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma.
Blood Adv., 6 (2).
S. 515 - 521.
AMSTERDAM:
ELSEVIER.
ISSN 2473-9537
Weisel, Katja, Besemer, Britta, Haenel, Mathias, Lutz, Raphael, Mann, Christoph, Munder, Markus, Goerner, Martin, Reinhardt, Hans Christian, Nogai, Axel, Ko, Yon-Dschun, De Wit, Maike, Salwender, Hans, Scheid, Christoph, Graeven, Ullrich, Peceny, Rudolf, Staib, Peter, Dieing, Annette, Jauch, Anna, Zago, Manola, Benner, Axel, Tichy, Diana, Bokemeyer, Carsten, Goldschmidt, Hartmut and Leypoldt, Lisa B. (2022). Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma: Planned Interim Analysis of the GMMG-Concept Trial. Blood, 140. S. 1836 - 1839. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Wuchter, Patrick, Bertsch, Uta, Salwender, Hans-Juergen, Munder, Markus, Haenel, Mathias, Benner, Axel, Becker, Natalia, Fenk, Roland, Duerig, Jan, Blau, Igor Wolfgang, Lisenko, Katharina, Hillengass, Jens, Raab, Marc S., Baertsch, Marc Andrea, Seidel-Glaetzer, Andrea, Ho, Anthony D., Graeven, Ullrich, Scheid, Christof, Weisel, Katja and Goldschmidt, Hartmut (2016). Evaluation of Stem Cell Mobilization in Patients with Multiple Myeloma after Lenalidomide-Based Induction Chemotherapy within the GMMG-HD6 Trial. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020